Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications

Journal of Pineal Research

Volumn 22, Issue 1, 1997, Pages 45-51

  Yeleswaram, Krishnaswamy ^a   McLaughlin, Lee G ^a   Knipe, Jay O ^a   Schabdach, David ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

Bioavailability; Dog; Melatonin; Monkey; Pharmacokinetics; Rat

Indexed keywords

MELATONIN;

ANIMAL; ARTICLE; BIOAVAILABILITY; BLOOD; CELL STRAIN CACO 2; CHEMISTRY; DISEASE MODEL; DOG; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MACACA; MALE; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT; ULTRAVIOLET SPECTROPHOTOMETRY;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOGS; HUMANS; INJECTIONS, INTRAVENOUS; LIVER; MACACA FASCICULARIS; MALE; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0030642008     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1997.tb00302.x     Document Type: Article

References (23)

1. ALDHOUS, M., C. FRANEY, J. WRIGHT, J. ARENDT (1985) Plasma concentrations of melatonin in man following oral absorption of different preparations. Br. J. Clin. Pharmacol. 19:517-521.
2. ARTURSSON, P., J. KARLSSON (1991) Correlation between oral absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175:880-885.
3. COSTA, E.J.X., R.H. LOPES, M.T. LAMY-FREUND (1995) Permeability of pure lipid bilayers to melatonin. J. Pineal Res. 19:123-126.
4. DAVIES, B., T. MORRIS (1993) Physiological parameters in laboratory animals and humans. Pharm. Res. 10:1093-1096.
5. GIBBS, F.P., J. VRIEND (1981) The half-life of melatonin elimination from rat plasma. Endocrinology 109:1796-1798.
6. HOUSTON, J.B. (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47:1469-1479.
7. IGUCHI, H., K. KATO, H. IBAYASHI (1982) Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J. Clin. Endocrinol. Metab. 54:1025-1027.
8. KOPIN, I.J., C.M.B. PARE, J. AXELROD, H. WEISSBACH (1961) The fate of melatonin in animals. J. Biol. Chem. 235:3072-3075.
9. LANE, E.A., H.B. Moss (1985) Pharmacokinetics of melatonin in man: first-pass hepatic metabolism. J. Clin. Endocrinol. Metab. 61:1214-1216.
10. MALLO, C., R. ZAIDAN, G. GALY, E. VERMUELEN, J. BRUN, G. CHAZOT, B. CLAUSTRAT (1990) Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur. J. Clin. Pharmacol. 38:297-301.
11. MATTHEWS, C.D., D.J. KENNAWAY, A.J.G. FELLENBERG, G. PHILLIPOU, L.W. COX, R.F. SEAMARK (1981) Melatonin in man. Adv. Biosci. 29:371-381.
12. OZAKI, Y., H.J. LYNCH, R.J. WURTMAN (1976) Melatonin in rat pineal, plasma and urine: 24-hour rhythmicity and effect of chlorpromazine. Endocrinology 98:1418-1424.
13. RAYNAUD, F., F. MAUVIARD, M. GEOFFRIAU, B. CLAUSTRAT, P. PEVET (1993) Plasma 6-hydroxymelatonin, 6-sulfatoxymelatonin and melatonin kinetics after melatonin administration to rats. Biol. Signals 2:359-366.
14. REPPERT, S.M., M.J. PERLOW, L. TAMARKIN, D. KLEIN (1979) A diurnal melatonin rhythm in primate cerebrospinal fluid. Endocrinology 104:295-301.
15. SACK, R.L., A.J. LEWY, M.L. BLOOD, J. STEVENSON, L.D. KEITH (1991) Melatonin administration to blind people: phase advances and entrainment. J. Biol. Rhythms 6:249-261.
16. SCHEDL, H.P. (1965) Absorption of steroid hormones from the human small intestine. J. Clin. Endocrinol. Metab. 25:1309-1316.
17. VAKKURI, O., J. LEPPALUOTO, A. KAUPPILA (1985) Oral administration and distribution of melatonin in human serum, saliva and urine. Life Sci. 37:489-495.
18. WALDHAUSER, F., M. WALDHAUSER, H.R. LIEBERMAN, M. DENG, H.J. LYNCH, R.J. WURTMAN (1984) Bioavailability of oral melatonin in humans. Neuroendocrinology 39:307-313.
19. WETTERBERG, L. (1978) Melatonin in humans: physiological and clinical studies. J. Neural Transmission, Suppl. 13:289-310.
20. WILKINSON, G.R., D.G. SHAND (1975) A physiological approach to hepatic drug clearance. Clin. Pharmacol. Then 18:377-390.
21. WILSON, G., J.F. HASSAM, C.J. DIX, I. WILLIAMSON, R. SHAH, M. MACKAY, P. ARTURSSON (1990) Transport and permeability properties of human Caco-2 cells: An in vitro model of the intestinal epithelial cell barrier. J. Control. Release 11:25-40.
22. WRIGHT, J., M. ALDHOUS, C. FRANEY, J. ENGLISH, J. ARENDT (1986) The effects of exogenous melatonin on endocrine function in man. Clin. Endocrinol. 24:375-382.
23. ZHDANOVA, I.V., R.J. WURTMAN, H.J. LYNCH, J.R. IVES, A.B. DOLLINS, C. MORABITO, J.K. MATHESON, D.L. SCHOMER(1995) Sleep-inducing effects of low doses of melatonin ingested in the evening. Clin. Pharmacol. Ther. 57:552-558.